Sigyn Therapeutics (SIGY) EPS (Diluted) (QoQ) (2017 - 2025)
Sigyn Therapeutics (SIGY) EPS (Diluted) (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 60.14% |
| Jun 30, 2025 | -117.06% |
| Mar 31, 2025 | -6.14% |
| Dec 31, 2024 | 58.41% |
| Sep 30, 2024 | -35.43% |
| Jun 30, 2024 | -13.05% |
| Mar 31, 2024 | 42.35% |
| Dec 31, 2023 | -5,119.67% |
| Sep 30, 2023 | -22.70% |
| Jun 30, 2023 | 98.80% |
| Mar 31, 2023 | -51.79% |
| Dec 31, 2022 | -4,616.37% |
| Sep 30, 2022 | -9.03% |
| Jun 30, 2022 | 1.73% |
| Mar 31, 2022 | 46.08% |
| Dec 31, 2021 | -85.93% |
| Sep 30, 2021 | -1.44% |
| Jun 30, 2021 | -36.45% |
| Mar 31, 2021 | 78.69% |
| Dec 31, 2020 | 86.73% |